Crinetics Pharmaceuticals Inc (NASDAQ:CRNX)
| 19.60 Delayed Data As of 4:00pm ET |  +0.24 / +1.24%Today’s Change | 15.91 Today|||52-Week Range 28.95 | -31.01% Year-to-Date |
Latest CRNX News | Press Releases
No recent news for Crinetics Pharmaceuticals Inc.
Today’s Trading
| Previous close | 19.36 |
| Today’s open | 19.64 |
| Day’s range | 19.21 - 19.96 |
| Volume | 23,237 |
| Average volume (3 months) | 312,501 |
| Market cap | $980.2M |
Data as of 4:00pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | -15.52% |
| Earnings growth (this year) | +3.01% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 1,012.96 |
| Price/Book | 2.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INVAInnoviva Inc | -0.31 | -2.09% |
| ---- | ||
| ACRSAclaris Therapeutics... | -1.41 | -8.90% |
| SNDXSyndax Pharmaceutica... | +0.13 | +0.68% |
Data as of 4:01pm ET, 06/24/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.64 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$107.6M |
| Net profit margin | -9,985.25% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
